Fundamental Analysis of AGENUS INC(NASDAQ:AGEN) stock

Fundamental Rating

Taking everything into account, AGEN scores 2 out of 10 in our fundamental rating. AGEN was compared to 588 industry peers in the Biotechnology industry. AGEN has a bad profitability rating. Also its financial health evaluation is rather negative. AGEN is valued quite expensive, but it does show an excellent growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year AGEN has reported negative net income.

AGEN had a negative operating cash flow in the past year.

AGEN had negative earnings in each of the past 5 years.

AGEN had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -78.38%, AGEN is doing worse than 71.11% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-78.38%
ROE	N/A
ROIC	N/A

ROA(3y)-45.6%

ROA(5y)-58.14%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 97.98%, AGEN belongs to the top of the industry, outperforming 98.29% of the companies in the same industry.

AGEN's Gross Margin has been stable in the last couple of years.

AGEN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	97.98%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.25%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

AGEN does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, AGEN has more shares outstanding

AGEN has more shares outstanding than it did 5 years ago.

The debt/assets ratio for AGEN is higher compared to a year ago.

2.2 Solvency

AGEN has an Altman-Z score of -7.82. This is a bad value and indicates that AGEN is not financially healthy and even has some risk of bankruptcy.

With a Altman-Z score value of -7.82, AGEN is not doing good in the industry: 72.14% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-7.82

ROIC/WACCN/A

WACC9.21%

2.3 Liquidity

A Current Ratio of 0.44 indicates that AGEN may have some problems paying its short term obligations.

Looking at the Current ratio, with a value of 0.44, AGEN is doing worse than 96.07% of the companies in the same industry.

AGEN has a Quick Ratio of 0.44. This is a bad value and indicates that AGEN is not financially healthy enough and could expect problems in meeting its short term obligations.

AGEN has a worse Quick ratio (0.44) than 95.90% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.44
Quick Ratio	0.44

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 10.13% over the past year.

AGEN shows a strong growth in Revenue. In the last year, the Revenue has grown by 59.49%.

AGEN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 33.55% yearly.

EPS 1Y (TTM)10.13%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q45.83%

Revenue 1Y (TTM)59.49%

Revenue growth 3Y21.02%

Revenue growth 5Y33.55%

Revenue growth Q2Q195.07%

3.2 Future

The Earnings Per Share is expected to grow by 12.46% on average over the next years. This is quite good.

AGEN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 34.68% yearly.

EPS Next Y53.45%

EPS Next 2Y0.58%

EPS Next 3Y8.14%

EPS Next 5Y12.46%

Revenue Next Year61.03%

Revenue Next 2Y29.43%

Revenue Next 3Y35.85%

Revenue Next 5Y34.68%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

AGEN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year AGEN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y0.58%

EPS Next 3Y8.14%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

AGEN does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

AGENUS INC

NASDAQ:AGEN (4/18/2024, 7:00:00 PM)

Premarket: 5.05 +0.08 (+1.61%)

4.97

-0.43 (-7.96%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap2.08B

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-78.38%
ROE	N/A
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	97.98%
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.5

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	0.44
Quick Ratio	0.44
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)10.13%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next Y53.45%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)59.49%

Revenue growth 3Y21.02%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

AGENUS INC (AGEN)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens